Intrauterine Insemination Devices Market Trends

  • Report ID: 4279
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Intrauterine Insemination Devices Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Incidence of PCOS– The Centers for Disease Control and Prevention (CDC) estimates that around 6% to 12% of women in the United States suffer from polycystic ovary syndrome, which amounts to roughly 5 million of them.

PCOS causes hyperandrogenism and oligo-anovulation that are directly associated with infertility. A large number of women suffer from PCOS across the globe. For instance, approximately 75% of women worldwide are living with infertility owing to PCOS. This is considered to be one of the main reasons for infertility in women and it is expected to increase the global intrauterine insemination devices market size.

  • Surge in Drug Abuse – Almost 11 million people around the world consume psychoactive drugs, as per the data collected by the World Health Organization (WHO). This causes infertility in many couples and is estimated to drive the intrauterine insemination devices market growth. It has been observed that extreme consumption of drugs can reduce the chance of having a baby by reducing fertility in both men and women.

  • Increment in Smoking Habits – In 2019, there were more than a billion smokers, according to a comprehensive study on worldwide smoking trends. This affects fertility and is predicted to increase the demand for artificial insemination. Smoking habits are scientifically proven that can make the process of conceiving a child quite complex since exposure to smoking can damage the reproductive system and harm the DNA in sperm.

  • Rise in the Number of Cancer Cases and Chemotherapy – Cancer treatments may lead to poor reproductive health. According to the National Cancer Institute, cancer incidence is calculated to be approximately 442 per 100,000 people globally every year. Chemotherapies have been observed to affect ovaries by making them stop releasing estrogen and eggs.

  • Higher Prevalence of Obesity – As of 2019, there were about 2500 million overweight people around the World. Obesity affects nearly 39% of the global population. This condition is predicted to boost the global intrauterine insemination devices market as obesity may lead to the inability to conceive. Additionally, 6% of women worldwide experience fertility struggles owing to obesity.

Challenges

  • Risk of Infection - There is a possibility of infection when using intrauterine insemination devices. For instance, if the bacteria present in the vagina reach the uterus during the insemination procedure, it can cause infection. The symptoms include pelvic pain, chills, and fever, and there can also be light vaginal bleeding. Hence, this factor is estimated to hamper the market growth over the forecast period.
  • Higher Costs Associated with the Treatment
  • Preference for Alternative Procedures

Base Year

2024

Forecast Year

2025-2037

CAGR

3.9%

Base Year Market Size (2024)

USD 43.14 billion

Forecast Year Market Size (2037)

USD 70.94 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intrauterine insemination devices is assessed at USD 45.87 billion.

The intrauterine insemination devices market size was valued at USD 43.14 billion in 2024 and is expected to reach USD 70.94 billion by 2037, expanding at around 3.9% CAGR during the forecast period i.e., between 2025-2037. Rise in the number of cancer cases, chemotherapy and the increasing incidence of PCOS will boost the market growth.

North America industry is likely to account for largest revenue share by 2037, attributed to increasing incidence of infertility across the region.

The major players in the market are The Cooper Companies, Inc., Cook Group Incorporated, Kitazato Corporation., Rocket Medical plc, Prince Medical SAS, Gynotec B.V., SURGIMEDIK Healthcare India Pvt. Ltd., MedGyn Products, Inc., Meditech Devices Pvt Ltd, Biorad Medisys Private Limited
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos